Welcome to our dedicated page for Aptargroup SEC filings (Ticker: ATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AptarGroup, Inc. (ATR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a New York Stock Exchange-listed issuer, Aptar files current reports, annual and quarterly reports and other documents that explain its financial condition, capital structure and material events affecting the business.
Investors can review Form 8-K filings for announcements such as quarterly results and financing transactions. For example, a Form 8-K dated November 20, 2025 describes an underwritten public offering of 4.750% senior notes due 2031, including key terms of the notes, redemption provisions and related underwriting agreements. Other 8-K filings reference the release of quarterly earnings information for periods such as the quarter ended September 30, 2025.
Alongside current reports, users can consult Aptar’s periodic filings, including Form 10-K annual reports and Form 10-Q quarterly reports, which typically provide segment information for Aptar Pharma, Aptar Beauty and Aptar Closures, as well as discussions of risk factors and liquidity. Filings related to debt instruments, indentures and other agreements give additional insight into the company’s capital structure.
Stock Titan enhances these documents with AI-powered tools that summarize key points, highlight significant terms and help explain complex sections in plain language. Users can quickly identify items such as new debt offerings, results of operations disclosures and other material events, while retaining the ability to read the full original filings. This page is a starting point for analyzing how Aptar reports its performance, governance and financing activities to regulators and the market.
APTARGROUP, INC. President, Asia, Xiangwei Gong reported a tax-withholding disposition of 180 shares of common stock at
APTARGROUP, INC. Chief Human Resources Officer Shiela Vinczeller reported a small share disposition related to taxes. On the reported date, 168 shares of common stock were delivered at
APTARGROUP President and CEO Stephan B. Tanda reported a tax-related share disposition. On February 23, 2026, 987 shares of common stock were withheld at $145.72 per share to cover tax liability, leaving him with 203,999 directly owned shares and 3,127 shares held indirectly through a 401(k) trust.
APTARGROUP, INC. Segment President Gael Touya reported an open-market sale of company stock. On February 18, 2026, he sold 3,500 shares of common stock at a weighted average price of $141.3539 per share, executed in multiple trades between $141.2250 and $141.8050. After this transaction, he directly owned 27,963 shares of AptarGroup common stock.
Registrant filed a Form 144 proposing the sale of 3,500 common shares.
The filing lists an aggregate offering price of $494,738.65 and states shares outstanding were 64,379,735 as of 02/18/2026. The securities are described as restricted stock vesting under a registered plan with vesting entries including 485 (02/25/2022) and 1,417 (03/25/2022).
AptarGroup, Inc. executive share sale reported. Segment President Marc Prieur sold 2,000 shares of AptarGroup common stock on February 10, 2026 at a price of $137.81 per share. After this transaction, he beneficially owns 13,745 shares of AptarGroup common stock, held directly.
Morgan Stanley has disclosed a significant passive stake in AptarGroup, Inc. (ATR). As of 12/31/2025, Morgan Stanley reports beneficial ownership of 4,019,724 shares of AptarGroup common stock, representing 6.1% of the outstanding class.
The firm reports no sole voting or dispositive power. It has shared voting power over 3,688,486 shares and shared dispositive power over 3,885,398 shares. Morgan Stanley certifies that these securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of AptarGroup. This filing is Amendment No. 10 to its Schedule 13G.
AptarGroup, Inc. shareholder has filed a Form 144 notice to sell 2,000 common shares. The planned sale is through UBS Switzerland AG on the NYSE, with an aggregate market value of $272,000 and 66,543,252 shares outstanding. The approximate sale date indicated is February 9, 2026.
The 2,000 common shares were acquired on March 23, 2024 via restricted stock units (RSUs) and performance stock units (PSUs) granted by AptarGroup, Inc., and paid in the form of these equity awards.
AptarGroup, Inc. is a global supplier of dosing, dispensing and protection technologies for pharmaceuticals, beauty, personal care, home care, food and beverage products. The company operates three segments: Pharma, Beauty and Closures.
In 2025, Pharma generated about 46% of net sales and 69% of adjusted EBITDA (excluding non-allocated corporate costs), supplying nasal spray pumps, inhaler valves, injectable elastomer components, active material science solutions and digital health tools. Beauty contributed roughly 35% of net sales with pumps, airless systems and valves for fragrance, skincare, cosmetics and personal care. Closures represented about 19% of net sales, focusing on dispensing closures for food, beverage and personal care applications.
Aptar is geographically diversified, with 57 manufacturing facilities worldwide and approximately 14,000 employees, and no single customer exceeding 4% of 2025 net sales. The company emphasizes sustainability, including science-based emissions targets, recyclable and PCR-based packaging solutions, and multiple external recognitions for environmental and social performance. Recent portfolio moves include acquiring Sommaplast for $27 million, increasing ownership in BTY to 80% for about $29 million, and a 40% stake in Goldrain for about $99 million.
Key risks highlighted include macroeconomic weakness, geopolitical tensions and tariffs, supply chain and single‑source material dependence, cybersecurity threats, foreign currency volatility, labor relations, environmental and packaging regulations, tax changes, climate-related impacts and exposure to routine litigation and regulatory oversight.